Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-24-009779
Filing Date
2024-10-21
Accepted
2024-10-18 18:56:22
Documents
12

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 3933756
2 GRAPHIC img192126064_0.jpg GRAPHIC 6826
3 GRAPHIC img192126064_1.jpg GRAPHIC 47056
4 GRAPHIC img192126064_2.jpg GRAPHIC 531755
5 GRAPHIC img192126064_3.jpg GRAPHIC 20707
6 GRAPHIC img192126064_4.jpg GRAPHIC 1218487
7 GRAPHIC img192126064_5.jpg GRAPHIC 967527
8 GRAPHIC img192126064_6.jpg GRAPHIC 44986
9 GRAPHIC img192126064_7.jpg GRAPHIC 28516
10 GRAPHIC img192126064_8.jpg GRAPHIC 77611
11 GRAPHIC img192126064_9.jpg GRAPHIC 1056366
12 GRAPHIC img192126064_10.jpg GRAPHIC 6826
  Complete submission text file 0000950123-24-009779.txt   8902203
Mailing Address 117 E. LOUISA STREET #561 SEATTLE WA 98102
Business Address 117 E. LOUISA STREET #561 SEATTLE WA 98102 206-701-5840
Aurion Biotech, Inc. (Filer) CIK: 0001924356 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-07511 | Film No.: 241381682
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)